Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

AshHill Biomedical

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$10M
Portfolio companies 2
Rounds per year 0.30
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Key employees 1
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Therapeutics
  • Pharmaceuticals
  • Drug Discovery
  • Health Care
Summary

AshHill Biomedical appeared to be the VC, which was created in 2011. The fund was located in North America if to be more exact in United States. The main department of described VC is located in the Cincinnati.

Among the various public portfolio startups of the fund, we may underline Heart Metabolics, Armetheon For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Therapeutics, Biotechnology. The fund has no specific favorite in a number of founders of portfolio startups.

The important activity for fund was in 2014. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year. Considering the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations.

The usual cause for the fund is to invest in rounds with 3-4 partakers. The meaningful sponsors for the fund in investment in the same round are venBio Partners, Seroba Life Sciences, Life Sciences Partners. In the next rounds fund is usually obtained by venBio Partners, Seroba Life Sciences, Life Sciences Partners.

Read more

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Asia Plus Chicago, Illinois, United States
Campus Fund -
Cherry Tree Investments California, Los Angeles, United States
China Unicom Beijing, Beijing, China
Coherent California, Santa Clara, United States
CommonSpirit -
Draper Cambridge, Massachusetts, United States
EXPERT DOJO California, Santa Monica, United States
Formica Ventures -
Go-Ventures Indonesia, Jakarta, Jakarta Raya
Kaedan Capital Israel, Tel Aviv, Tel Aviv
Kedaara Capital India, Maharashtra, Mumbai
Loxbridge Research England, London, United Kingdom
Merieux Developpement France, Lyon, Rhone-Alpes
Netmarble Seoul, Seoul-t'ukpyolsi, South Korea
NREP -
Parent Project Muscular Dystrophy -
San Diego Venture Partners -
Shenzhenshi Huaxia Dexin Jijin Guanli Youxian Gongsi China, Guangdong Province, Huizhou
Xiamen Torch Group Co China, Fujian, Xiamen

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Armetheon

Biopharma
Biotechnology
Pharmaceutical
$7M28 Aug 2014 California, United States

Heart Metabolics

Biotechnology
Drug Discovery
Health Care
Pharmaceuticals
Therapeutics
$20M16 Apr 2014 San Francisco, California, United States

Heart Metabolics

Biotechnology
Drug Discovery
Health Care
Pharmaceuticals
Therapeutics
$4M04 Jan 2013 San Francisco, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent AshHill Biomedical?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 3
Average round size 10M
Rounds per year 0.30
Peak activity year 2014
Lead investments 1
Follow on index 0.33
Group Appearance index 0.67

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Armetheon

Biopharma
Biotechnology
Pharmaceutical
$7M28 Aug 2014 California, United States

Heart Metabolics

Biotechnology
Drug Discovery
Health Care
Pharmaceuticals
Therapeutics
$20M16 Apr 2014 San Francisco, California, United States

Heart Metabolics

Biotechnology
Drug Discovery
Health Care
Pharmaceuticals
Therapeutics
$4M04 Jan 2013 San Francisco, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: